("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company ... The data were presented at the 2023 San Antonio Breast Cancer Symposium by G.
News
- Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of ...
- Anixa Biosciences to Host Conference Call This Evening to Discuss Positive ... - InvestorsObserver
("Anixa" or the "Company") (NASDAQ: ANIX), a clinical-stage biotechnology ... San Antonio Breast Cancer Symposium ("SABCS"). All interested parties ...
- Oncolytics Biotech® and SOLTI Present Positive Translational Data at SABCS
... San Antonio Breast Cancer Symposium (SABCS). "Translational data presented from the AWARE-1 study at SABCS showed that pelareorep induced the ...
- Four people in Virginia with Russian military connections are charged with war crimes | TPR
Bioscience-Medicine · Border & Immigration · Business · Criminal Justice · Education ... San Antonio · Technology & Entrepreneurship · Texas · TPR ...
- Neoadjuvant chemotherapy may help some breast cancer patients skip regional nodal irradiation
Biomedical technology · Cardiology · Dentistry · Diabetes · Diseases, Conditions ... San Antonio Breast Cancer Symposium, held December 5–9, 2023.